You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antirheumatic%20Agents

Showing 1 - 25 of 5,462
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hydroxychloroquine, Antimalarials, Enzyme Inhibitors Trial in Mexico City (Hydroxychloroquine Sulfate, Bromhexine 8 MG)

Enrolling by invitation
  • Hydroxychloroquine
  • +3 more
  • Hydroxychloroquine Sulfate
  • Bromhexine 8 MG
  • Mexico City, Cdmx, Mexico
    National Institute of Rehabilitation, Luis Guillermo Ibarra Ibar
Jun 26, 2021

Myocardial Infarction, Acute Coronary Syndrome, Inflammation Trial in Finland (Hydroxychloroquine, Placebo)

Completed
  • Myocardial Infarction
  • +5 more
  • Helsinki, Finland
  • +5 more
Jun 6, 2020

Rheumatoid Arthritis (RA) Trial in China, Korea, Republic of, Taiwan (Peficitinib, Plaebo, Disease-modifying antirheumatic drugs

Completed
  • Rheumatoid Arthritis (RA)
  • Anhui, China
  • +42 more
Jan 7, 2023

Giant Cell Arteritis Trial in Canada, United States (Abatacept, Placebo)

Recruiting
  • Giant Cell Arteritis
  • Rochester, Minnesota
  • +5 more
Jul 11, 2022

Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory DLBCL Trial in Canada (DPX-Survivac, Pembrolizumab,

Active, not recruiting
  • Adult Diffuse Large Cell Lymphoma
  • +2 more
  • DPX-Survivac
  • +2 more
  • Calgary, Alberta, Canada
  • +5 more
Nov 9, 2022

Rheumatoid Arthritis Trial in Cairo (Cilostazol 100 MG, conventional synthetic antirheumatic drugs)

Recruiting
  • Rheumatoid Arthritis
  • Cilostazol 100 MG
  • conventional synthetic antirheumatic drugs
  • Cairo, Egypt
    Al-Zahraa Hospital
Dec 26, 2022

Tofacitinib Special Investigation for Rheumatoid Arthritis

Completed
  • Rheumatoid Arthritis
  • Tofacitinib (Xeljanz)
  • Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc
  • Tokyo, Japan
    (unnamed)
Sep 27, 2021

Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))

Not yet recruiting
  • Rheumatoid Arthritis
  • Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
  • (no location specified)
Nov 12, 2021

Tumor Necrosis Factor-alpha Antagonists in Rheumatoid Arthritis.

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Infliximab: Adalimumab; Etanercept;
  • Sulaymaniyah, Kurdistan Region, Iraq
    Hiwa Khidhir Saaed
May 12, 2022

Rheumatoid Arthritis Trial in Glasgow (Active Stimulation)

Recruiting
  • Rheumatoid Arthritis
  • Active Stimulation
  • Glasgow, United Kingdom
    Greater Glasgow Health Board
Oct 25, 2021

Diffuse Cutaneous Systemic Sclerosis Trial in London (Brentuximab Vedotin)

Recruiting
  • Diffuse Cutaneous Systemic Sclerosis
  • Brentuximab Vedotin
  • London, Ontario, Canada
    Rheumatology Clinic, St. Joseph's Health Care
Feb 3, 2022

Rheumatoid Arthritis Trial in Montpellier (Abatacept (M3-M12), TNF Inhibitor (M3-M12), TNF Inhibitor (M0-M3))

Not yet recruiting
  • Rheumatoid Arthritis
  • Abatacept (M3-M12)
  • +2 more
  • Montpellier, France
    Centre Hospitalier Universitaire de Montpellier
Jun 16, 2022

Rheumatoid Arthritis Trial in United States (procedure, drug, device)

Recruiting
  • Rheumatoid Arthritis
  • Implant Procedure
  • +3 more
  • Birmingham, Alabama
  • +33 more
Jan 3, 2023

Corona Virus Infection Trial in Bogota (Colchicine 0.5 MG, CONTROL GROUP)

Terminated
  • Corona Virus Infection
  • Colchicine 0.5 MG
  • CONTROL GROUP
  • Bogota, Cundinamarca, Colombia
    Fundación Universitaria de Ciencias de La Salud
Feb 7, 2022

Rheumatoid Arthritis Trial ("apigenin" and "glycyrrhizin", "glycyrrhizin" and "boswellic acid", "")

Not yet recruiting
  • Rheumatoid Arthritis
  • "apigenin" and "glycyrrhizin"
  • +2 more
  • (no location specified)
Mar 27, 2023

Rheumatoid Arthritis Trial in Norway (TNF inhibitors, Synthetic DMARD(s), Co-medication: Synthetic DMARDs)

Active, not recruiting
  • Rheumatoid Arthritis
  • TNF inhibitors
  • +2 more
  • Bergen, Norway
  • +9 more
Sep 14, 2020

Axial Spondyloarthritis, Arthritis, Rheumatoid Trial in Portugal (biological disease-modifying antirheumatic drugs (bDMARDs))

Recruiting
  • Axial Spondyloarthritis
  • Arthritis, Rheumatoid
  • biological disease-modifying antirheumatic drugs (bDMARDs)
  • Aveiro, Portugal
  • +9 more
Jul 12, 2021

Rheumatoid Arthritis Trial in Lebanon (Abatacept, DMARDs)

Active, not recruiting
  • Rheumatoid Arthritis
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Jul 22, 2022

The Norwegian Antirheumatic Drug Register

Recruiting
  • Inflammatory Joint Diseases
    • Drammen, Buskerud, Norway
    • +5 more
    Aug 19, 2022

    Arthritis, Rheumatoid, Arthritis, Psoriatic, Spondyloarthritis Trial in Caba, Ciudad Autonoma Buenos Aires (DMARDs, biologic

    Recruiting
    • Arthritis, Rheumatoid
    • +2 more
    • Caba, Buenos Aires, Argentina
    • +1 more
    Mar 26, 2021

    SAPHO Syndrome Trial in Warsaw (Etanercept, Placebo)

    Recruiting
    • SAPHO Syndrome
    • Warsaw, Mazowieckie, Poland
      Centrum Wsparcia Badań Klinicznych
    Aug 29, 2023

    Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)

    Terminated
    Has Results
    • Rheumatoid Arthritis
    • Pondicherry, India
      Department of Clinical Immunology , Jawaharlal Institute of Post
    Jul 25, 2021

    Predictive Factors for COVID-19 in Rheumatology

    Not yet recruiting
    • Rheumatic Diseases
    • Covid19
    • Disease-modifying antirheumatic drugs (DMARDs)
    • (no location specified)
    Sep 24, 2020

    COVID-19 Trial in United States (Hydroxychloroquine, Placebo oral tablet)

    Completed
    Has Results
    • COVID-19
    • Aurora, Colorado
    • +33 more
    Oct 8, 2021

    Psoriatic Arthritis Trial in Worldwide (Deucravacitinib, Placebo, Apremilast)

    Recruiting
    • Psoriatic Arthritis
    • Birmingham, Alabama
    • +136 more
    Jul 29, 2022